Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis

McInnes, IB; Anderson, JK; Magrey, M; Merola, JF; Liu, Y; Kishimoto, M; Jeka, S; Pacheco-Tena, C; Wang, X; Chen, L; Zueger, P; Liu, J; Pangan, AL; Behrens, F

McInnes, IB (corresponding author), Univ Glasgow, Glasgow Biomed Res Ctr, 120 Univ Pl, Glasgow G12 8QQ, Lanark, Scotland.

NEW ENGLAND JOURNAL OF MEDICINE, 2021; 384 (13): 1227

Abstract

BackgroundThe Janus kinase inhibitor upadacitinib is a potential treatment for psoriatic arthritis. The efficacy and safety of upadacitinib as compare......

Full Text Link